Bernadine Healy, MD, a cardiologist, was the first woman Director of the National Institutes of Health (1991–1993); Dean of Ohio State University College of Medicine (1995–1999); President of the American Heart Association (1998–1999); Deputy Director of the President’s Council of Advisors on Science and . . . Continue reading →
The Chronicle of Higher Education looks at the increasingly dark side of conflicts of interest in academia. Continue reading →
We are no longer "blowin’ in the wind." A growing number of prominent physician-scientists, including several former journal editors, and New York Times columnists, have written sobering critiques about the corrupting impact pharmaceutical industry influence has had on medicine. Continue reading →
Why Has Columbia Expended So Much Effort to Avoid the Conclusion of Patient Harm? Continue reading →
AHRP proposes a multi-disciplinary team of independent scientists to review ALL of Dr. Joseph Biederman’s publications and supporting documents, including: research protocols, consent forms, and the original (of course, anonymized) data sets with associated code books for all pediatric studies. Continue reading →
April 14: the FDA announced that Coast IRB "has agreed to voluntarily halt some aspects of its clinical trial oversight operations due to serious concerns about the company’s ability to protect human subjects participating in clinical trials."
Continue reading →
Another research scam uncovered by the GAO sting involved a "bogus IRB with a pet dog as its CEO." Continue reading →
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion. Continue reading →
What does the "Gillberg affair" suggest about the integrity of the data underlying the DAMP-ADHD hypothesis?
Medical researchers who commit fraud and research misconduct are caught only when a person of conscience steps up to the plate and blows the whistle. There are no systemic, independent checks and balances to prevent research fraud or abuse of patients. Continue reading →
FDA Underhanded Tactics Against Medical Officer Who Blew the Whistle Mon, 29 Nov 2004 The Food and Drug Administration is the epicenter of a collision between medical officers in the drug safety office and senior officials in managerial positions whose focus is . . . Continue reading →
Integrity in Scientific Research : Peer review ineffective – Institute of Medicine / Lancet / Science August 25, 2002 Integrity in Scientific Research: Creating an Environment That Promotes Responsible Conduct This report and by the Institute of Medicine (IOM) and two current . . . Continue reading →